Events

Ono Pharma is inviting early-stage life sciences companies to apply for their 2026 LabCentral Golden Ticket!Ono will award one promising early-stage company with a $50,000 credit towards space and services available at LabCentral's flagship site at 700 Main Street in Cambridge for use within a 13-month period, beginning upon receipt.

Ono is keen to see emerging open innovations in the life science field, which would have potential synergy with its current and future R&D activities. To learn more about Ono's R&D philosophy, visit their website here.

Here’s what you can expect with an Ono - LabCentral Golden Ticket award:

• $50,000 credit towards space available at LabCentral
• Access to the shared amenities and services provided at LabCentral
• Working closely with Ono's R&D scientists, business leaders and global network partners

To apply, send your non-confidential company presentation, as a PDF, to labcentral-goldenticket2026_ml@ono-pharma.com by May 29th, 2026.

Once submitted, your company’s proposal will be reviewed by Ono’s internal committee and finalist companies will be notified and invited to present to Ono using a web-meeting system in July 2026. The winner will be notified soon thereafter and presented with the awards.

About Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd. delivers innovative medicines for patients worldwide. Upholding its philosophy of “Dedicated to the Fight against Disease and Pain,” Ono targets areas with unmet medical needs including oncology, immunology & inflammation, and neurology, and fosters partnerships with academic and biotech organizations to accelerate drug discovery. Through its affiliate, Deciphera Pharmaceuticals, Ono is accelerating clinical development and commercial operations in the US and Europe to drive global business expansion and further its commitment to patient care. For more information, please visit the company's website at https://www.ono-pharma.com/en.

Dedicated to the Fight against Disease and Pain | Ono Pharmaceutical Co., Ltd.